Skip to main content
. 2004 Nov 3;54(4):383–388. doi: 10.1007/s00262-004-0614-9

Fig. 2.

Fig. 2

Appearance of BCL1 leukemia in untreated adoptive recipient BALB/c mice receiving 105 spleen cells obtained from each experimental group (i.e., leukemia control, SCT control, SCT+MMF 120 mg/kg, and SCT+MMF 200 mg/kg; n=16 for each group).